Researchers Awarded £2.6M to Develop Preclinical Lead Drug Candidate for Advanced Prostate and Colorectal Cancers

Researchers at the University of Strathclyde have been awarded £2.6 million to develop a preclinical lead drug candidate targeted at advanced prostate and colorectal cancers.